Hung‐Chih Yang

11.0k total citations · 3 hit papers
183 papers, 7.8k citations indexed

About

Hung‐Chih Yang is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Hung‐Chih Yang has authored 183 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Epidemiology, 103 papers in Hepatology and 34 papers in Infectious Diseases. Recurrent topics in Hung‐Chih Yang's work include Hepatitis B Virus Studies (92 papers), Hepatitis C virus research (87 papers) and Liver Disease Diagnosis and Treatment (79 papers). Hung‐Chih Yang is often cited by papers focused on Hepatitis B Virus Studies (92 papers), Hepatitis C virus research (87 papers) and Liver Disease Diagnosis and Treatment (79 papers). Hung‐Chih Yang collaborates with scholars based in Taiwan, United States and Australia. Hung‐Chih Yang's co-authors include Jia‐Horng Kao, Pei‐Jer Chen, Robert F. Siliciano, Chun‐Jen Liu, Ding‐Shinn Chen, Tung‐Hung Su, Chen‐Hua Liu, Tai‐Chung Tseng, Joel N. Blankson and Chi‐Ling Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Hung‐Chih Yang

173 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

2012 555 citations Hung‐Chih Yang, Joel N. Blankson et al. profile →
Map-reduce-merge

2007 454 citations Hung‐Chih Yang et al. profile →
High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

2012 415 citations Tai‐Chung Tseng, Chun‐Jen Liu et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hung‐Chih Yang Taiwan	43	3.8k	3.2k	2.2k	1.6k	1.4k	183	7.8k
Avidan U. Neumann Israel	50	5.8k 1.6×	5.2k 1.6×	7.6k 3.5×	5.5k 3.4×	4.1k 2.9×	149	16.7k
Charles A. Boucher Netherlands	68	4.2k 1.1×	1.6k 0.5×	9.1k 4.2×	9.7k 6.0×	1.3k 0.9×	345	17.4k
Eric Rosenberg United States	68	3.3k 0.9×	642 0.2×	13.3k 6.1×	6.7k 4.1×	9.1k 6.5×	218	17.4k
Daniel R. Kuritzkes United States	75	3.2k 0.9×	938 0.3×	13.9k 6.4×	14.3k 8.8×	1.9k 1.4×	370	19.9k
Marco Ciotti Italy	36	1.5k 0.4×	347 0.1×	117 0.1×	1.1k 0.7×	261 0.2×	212	5.1k
Ross L. Coppel Australia	83	8.8k 2.3×	9.6k 3.0×	664 0.3×	1.2k 0.7×	5.8k 4.2×	474	24.4k
Tatsuo Miyamura Japan	68	9.6k 2.5×	12.3k 3.9×	799 0.4×	4.9k 3.0×	1.3k 0.9×	372	19.9k
Christopher Aiken United States	52	1.9k 0.5×	295 0.1×	7.0k 3.2×	4.2k 2.6×	2.1k 1.5×	130	9.4k
Morten Nielsen Denmark	73	3.0k 0.8×	276 0.1×	951 0.4×	3.7k 2.3×	12.1k 8.6×	278	25.8k
Alan S. Lapedes United States	24	1.6k 0.4×	104 0.0×	1.3k 0.6×	1.1k 0.7×	892 0.6×	52	4.5k

Countries citing papers authored by Hung‐Chih Yang

Since Specialization

Citations

This map shows the geographic impact of Hung‐Chih Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Chih Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Chih Yang more than expected).

Fields of papers citing papers by Hung‐Chih Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Chih Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Chih Yang. The network helps show where Hung‐Chih Yang may publish in the future.

Co-authorship network of co-authors of Hung‐Chih Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Chih Yang. A scholar is included among the top collaborators of Hung‐Chih Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Chih Yang. Hung‐Chih Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, R H, Linlin Zhou, Yu‐Chun Lin, et al.. (2025). A Machine Learning Framework for Cancer Prognostics: Integrating Temporal and Immune Gene Dynamics via ARIMA-CNN. Biomedicines. 13(11). 2751–2751.

Hsu, Chung‐Yao, Pei‐Yun Tsai, Jung‐Chen Lin, et al.. (2025). Polymerised superparamagnetic antigen presenting cell lymphocyte capture for enriching tumour reactive T-cells and neoantigen identification. Nature Communications. 16(1). 5088–5088.

Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2025). Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients. Hepatology. 83(1). 142–155. 1 indexed citations

Liao, Hsiu‐Jung, et al.. (2025). Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistence. Journal of Microbiology Immunology and Infection. 59(2). 172–180.

Tseng, Tai‐Chung, Shang‐Chin Huang, Chun‐Jen Liu, et al.. (2025). Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold. Gut. 74(11). 1896–1904. 1 indexed citations

Chang, Kai‐Chun, Tung‐Hung Su, Cho‐Kai Wu, et al.. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease is Associated with Increased Risks of Heart Failure. European Journal of Heart Failure. 27(3). 512–520. 12 indexed citations

Huang, Yu‐Shan, Szu‐Min Hsieh, Feng‐Chiao Tsai, et al.. (2024). Serological responses to COVID-19 vaccination in patients with chronic liver diseases. Journal of the Formosan Medical Association. 1 indexed citations

Yang, Hung‐Chih. (2024). Revisiting the natural history of chronic hepatitis B infection. Clinical Liver Disease. 23(1). e0195–e0195.

Lui, Grace, Grace Lai–Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, & Sun Hee Lee. (2023). Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia. HIV Medicine. 24(10). 1035–1044. 2 indexed citations

10.

Tseng, Tai‐Chung, Chun‐Jen Liu, Chun‐Ming Hong, et al.. (2023). Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels. Gastroenterology. 164(4). 669–679.e6. 13 indexed citations

11.

Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2023). HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative. JHEP Reports. 6(1). 100956–100956. 5 indexed citations

12.

Hong, Chun‐Ming, Chun‐Jen Liu, Shiou‐Hwei Yeh, et al.. (2021). Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses. 13(11). 2294–2294. 1 indexed citations

13.

Tseng, Tai‐Chung, Chun‐Jen Liu, Wanting Yang, et al.. (2021). Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. 53(8). 908–918. 12 indexed citations

14.

Seed, Clive R., et al.. (2020). Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period. Vox Sanguinis. 116(4). 379–387. 18 indexed citations

15.

Yang, Sheng‐Shun, Tung‐Hung Su, Hung‐Chih Yang, et al.. (2018). Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Journal of Hepatology. 68. S266–S266. 5 indexed citations

16.

Yang, Wanting, Liwei Wu, Tai‐Chung Tseng, et al.. (2016). Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95(10). e2995–e2995. 14 indexed citations

17.

Liu, Chen‐Hua, Cheng‐Chao Liang, Chun‐Jen Liu, et al.. (2015). Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping. Journal of Clinical Microbiology. 53(5). 1754–1757. 59 indexed citations

18.

Tseng, Tai‐Chung, Chun‐Jen Liu, Hung‐Chih Yang, et al.. (2014). Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64(2). 292–302. 84 indexed citations

19.

Tseng, Tai‐Chung, Chun‐Jen Liu, Tung‐Hung Su, et al.. (2012). Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation. The Journal of Infectious Diseases. 206(10). 1521–1531. 41 indexed citations

20.

Chase, Amanda J., Hung‐Chih Yang, Hao Zhang, Joel N. Blankson, & Robert F. Siliciano. (2008). Preservation of FoxP3 ⁺ Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4 ⁺ T-Cell Activation. Journal of Virology. 82(17). 8307–8315. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact